NCT00132158 ZD1839 and Oral Irinotecan in Treating Young Patients With Refractory Solid Tumors Status COMPLETED Phase PHASE1
NCT00115453 Boron Neutron Capture Therapy (BNCT) as Treatment of Glioblastoma Status TERMINATED Phase PHASE1/PHASE2
NCT00115440 BNCT to Treat Glioma That Has Progressed Following Radiotherapy Status COMPLETED Phase PHASE1/PHASE2
NCT00100802 Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas Status COMPLETED Phase PHASE2
NCT00088400 Comparison of TransMID vs Standard Treatment of Cancerous Brain Tumors Status COMPLETED Phase PHASE3
NCT00087451 Safety Study of AP23573 in Patients With Progressive or Recurrent Glioma (8669-023)(COMPLETED) Status COMPLETED Phase PHASE1
NCT00080054 A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas Status COMPLETED Phase PHASE1
NCT00074646 Phase I Trial of CC-8490 for the Treatment of Subjects With Recurrent/Refractory High-Grade Gliomas Status COMPLETED Phase PHASE1
NCT00068952 Study of IV Edotecarin Vs Temozolomide or Carmustine (BCNU) or Lomustine (CCNU) in Patients With Glioblastoma Multiforme Status COMPLETED Phase PHASE3
NCT00045968 Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer Status UNKNOWN Phase PHASE3
NCT00028158 Safety and Effectiveness Study of G207, a Tumor-Killing Virus, in Patients With Recurrent Brain Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00001148 Detecting Malignant Brain Tumor Cells in the Bloodstream During Surgery to Remove the Tumor Status COMPLETED Phase N/A